Trial intelligence / Profile preview

ESP-CNI: CNI-Free vs Low-Dose Tacrolimus in Elderly Kidney Transplant

NCT00912678Phase 4Completed

Sponsor
University of Lübeck
Start
Mar 2002
Primary completion
Jul 2006
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus, mycophenolate mofetil in kidney transplant rejection, sponsored by University of Lübeck. Started Mar 2002; status: completed.

02

Drugs

tacrolimusmycophenolate mofetil
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00912678.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00912678.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call